Category: Women’s health · Perimenopause · Sleep · Mental health · Skin
Late 40s, Periods Six Months Apart, Waking at 3 a.m., Cheek Melasma, and a Past Depression: Sorting Out Hormones, Sleep, Mood, and Skin, Plus Doctor Visits and Work Decisions
AI Overview / Quick Answer (BLUF)
Periods several months apart in the late 40s fit late perimenopause. Waking at 3 a.m. often reflects night-time hot flashes and lighter late-night sleep, but anyone with past depression should be screened for relapse. Cheek melasma tracks sunlight, visible light, and hormones. For self-harm thoughts, call emergency services.
menopause transition staging (STRAW+10),
perimenopausal depression guidelines,
and melasma treatment (Cochrane)
Warning signs ·
Which stage ·
3 a.m. waking ·
Past depression ·
Cheek melasma ·
Melasma care ·
Work ·
Doctor visit ·
FAQ
A reader’s question: recovering well after depression, but now waking at 3 a.m. every night, with melasma and less tolerance for work stress
A member of our community in her late 40s had depression about a year ago and recovered with exercise and meditation. Her periods have stretched from every 3 months to about every 6 months.
She now has melasma on both cheekbones, wakes around 3 a.m. almost every night, feels low, and work stress has her thinking about early retirement.
Short answer: all of this fits late perimenopause, but it should not be put down to hormones alone. A past depression raises the chance of relapse,
and early waking with low mood is a signal to screen. See a gynecologist and a mental-health professional in parallel. Melasma care can start now with the right kind of light protection.
If missed periods are making you feel bad about yourself, read
Missed periods and low mood: coping, doctor visits, and hormone therapy vs herbal remedies
Warning signs that should not wait
Direct answer: most perimenopause symptoms can wait for an appointment, but the signs below may mean severe depression, blood loss, heart disease, thyroid disease, or a skin lesion that needs checking.
Get help now: call emergency services (in Thailand, mental health hotline 1323 or emergency 1669)
- Thoughts of dying, self-harm, or not wanting to live: call 1323 or 1669 in Thailand or your local emergency number, go to an emergency room, and ask someone close to stay with you
- Soaking a pad every hour for 2 hours in a row with dizziness, a racing heart, or fainting
- Chest pain or pressure, breathlessness, or palpitations with near-fainting: do not assume it is a hot flash or stress
- Unable to eat, sleep, or look after yourself for several days, or hearing voices or having unusual thoughts
See a doctor within 1–2 weeks
- Low mood, loss of interest, or feeling worthless nearly every day for more than 2 weeks, especially if you have had depression before
- Bleeding for more than 7 days, between periods, after sex, or any bleeding after 12 months without a period
- Unplanned weight loss, tremor, a fast heart at rest, or unusual cold intolerance and fatigue, which can be thyroid symptoms
- A dark patch on one side only, with an irregular border, several colors, fast growth, or bleeding: not typical melasma
- A red rash on the cheeks with joint pain, fever, mouth ulcers, or heavy hair loss, unlike melasma, which is brown and not red
and recommend screening with standard questionnaires, especially for women with a past episode
(Maki 2018)
1. Periods six months apart: which stage of the transition is this?
Direct answer: a gap of 60 days or more between periods marks late perimenopause, and 12 months without a period defines menopause.
Hormones do not fall in a straight line in this phase; they swing widely and unpredictably, which can affect sleep, mood, and skin at the same time.
What the STRAW+10 criteria say
The standard criteria stage the transition by bleeding pattern. Early transition means cycle length changing by 7 days or more; late transition means a gap of 60 days or more,
and hot flashes become more common in this late stage. Periods moving from every 3 months to every 6 months therefore fall in late perimenopause
(STRAW+10)
Pregnancy is still possible, so contraception still matters
As long as periods still come occasionally, the ovaries can still release an egg in some cycles. Sexually active women should take a pregnancy test when a period is late and continue contraception until a doctor confirms menopause.
Symptoms come and go, and a single blood test often does not match how you feel that month.
2. Why wake at 3 a.m. every night and struggle to fall back asleep?
Direct answer: sleep is lighter in the second half of the night, so a mild hot flash, a full bladder, or racing thoughts wake you easily.
In someone with past depression, waking early and being unable to fall back asleep is also a symptom of depression, so both possibilities need checking.
Night-time hot flashes you may not notice
Following 3,045 women for 7 years showed that trouble falling and staying asleep rose with each stage of the transition, more frequent hot flashes meant worse sleep,
and falling estrogen was linked with night waking
(Kravitz 2008)
Laboratory sleep studies found that in the first half of the night most hot flashes came before the awakening, and a cool 18 °C room cut hot flashes in that period from 2.2 to 1.5.
In the second half of the night, dream (REM) sleep suppresses hot flashes, so some women wake first and then feel hot
(Freedman 2006)
Early-morning cortisol: real, but not the whole story
Cortisol naturally starts to rise in the early morning hours in everyone. A study of 132 women found night-time cortisol was linked with changes in sex hormones during the transition
(Woods 2009)
but there is no evidence that a 3 a.m. cortisol surge is the main cause. More frequent hot flashes are more clearly linked with night waking.
Early waking and a history of depression
The 2018 guideline notes that depressive symptoms in this phase often travel with hot flashes and insomnia, making them hard to separate. Short sleep worsens mood, and low mood makes waking easier
(Maki 2018)
If you wake feeling down straight away, feel worse in the morning than later in the day, or have lost interest in things you enjoyed, tell your doctor plainly that you have had depression before.
CBT-I: first-line treatment for chronic insomnia
The American College of Physicians recommends CBT-I as the first treatment for chronic insomnia in adults
(ACP 2016)
In 106 peri- and postmenopausal women with hot flashes, telephone CBT-I lowered insomnia scores by 9.9 points vs 4.7 points with menopause education
(McCurry 2016)
Share with insomnia severity scores in the normal range (McCurry 2016, MsFLASH)
- Awake at 3 a.m. for more than 20 minutes: get up, sit in dim light, do something calm, and return to bed when sleepy; do not keep checking the clock
- Get up at the same time every morning: even after a short night, so sleep pressure builds for the next night
- Cool room and breathable sleepwear: reduce hot flashes early in the night
- No caffeine after noon and no alcohol before bed: alcohol speeds sleep onset but causes waking late in the night
- Keep a 2-week sleep diary: waking times, sweating, bathroom trips, and mood on waking, then show it to your doctor
3. A past depression: how likely is it to come back now?
Direct answer: a history of depression is a major risk factor for depression coming back, and perimenopause adds its own risk on top.
Exercise and meditation genuinely help, but if low mood lasts more than 2 weeks, you should be assessed by a doctor rather than trying to push through alone.
Numbers from long-term studies
The SWAN study followed 221 women aged 42–52 and found the odds of major depression were 2–4 times higher during perimenopause or early postmenopause than before the transition,
and a history of major depression was a strong predictor throughout
(Bromberger 2011)
In 303 women, a family history of depression raised the odds of midlife depression (odds ratio 2.24), and late perimenopause or postmenopause raised them 3.01-fold
(Colvin 2017)
A meta-analysis of 17 studies and 16,061 women confirmed the risk during the transition (odds ratio 1.40)
(Badawy 2024)
Swinging hormones, not just low hormones
In women with no previous depression, the Penn Ovarian Aging Study found high depressive symptom scores 4.29 times more often during the transition and a diagnosis of depression 2.50 times more often,
and what tracked with mood was hormone fluctuation around each woman’s own average
(Freeman 2006)
Current models suggest these swings affect the brain’s stress-response system, so women who are sensitive to hormonal change find stress harder to handle
(Gordon 2015)
Already meditating: MBCT helps prevent relapse
An individual patient data meta-analysis of 9 trials with 1,258 people, mean age 47.1, 75.0% women, found that MBCT,
which combines mindfulness training with CBT-style thought work, lowered the risk of depressive relapse over 60 weeks (hazard ratio 0.69) and also did better than the other active treatments compared (hazard ratio 0.79)
(Kuyken 2016)
An existing meditation habit can grow into a structured program, but MBCT is for preventing relapse, not a replacement for treatment once depression has returned.
Exercise helps when it is regular
Pooling 25 randomized trials showed exercise clearly reduced depressive symptoms (standardized mean difference 1.11), especially moderate aerobic exercise with supervision
(Schuch 2016)
If you already exercise regularly and still feel low, it means another treatment needs adding, not that you are not doing enough.
- Do a mood screening with your doctor: share your past depression, the medicines you used, and which ones worked
- If an antidepressant worked before: name it; going back to a medicine that worked is often the first option
- Aim for moderate aerobic exercise: about 150 minutes a week, plus strength training on 2 days
- Protect sleep times, morning light, and social contact: all three help steady daily rhythms
and hormone therapy is not approved to treat depression.
3 a.m. waking, low mood, or periods spacing out: how severe are your menopause symptoms, and when should you not wait?
Get a severity analysis and personalized guidance from our Advisory team. The menopause symptom score grades hot flashes, sleep, mood, and cycle changes
as watch, book a doctor visit, or do not wait. It is not a diagnosis.
If you have thoughts of self-harm, call emergency services now without waiting for a score.
4. Melasma on both cheekbones: how much is it about menopause?
Direct answer: melasma is not caused by falling estrogen. It is linked with times of greater sex-hormone exposure, such as pregnancy and hormonal contraception, together with sunlight, visible light, and genetics.
Swinging hormones in perimenopause can darken melasma, but light is the trigger you can control most.
Triggers reported by women with melasma
A survey of 324 women at 9 clinics worldwide found an average onset age of 34, and 48% had a family history of melasma.
Melasma often began after pregnancy, and 25% of those who had used hormonal contraception said it first appeared after starting it. The authors concluded that melasma usually arises from several factors together
(Ortonne 2009)
Hormone receptors in melasma skin
Facial skin biopsies from 33 Korean women showed more progesterone receptors in the epidermis of melasma patches than in nearby skin,
and more estrogen receptor beta in the dermis around small blood vessels
(Jang 2010)
This helps explain why some patches respond more to hormones than others, but it does not mean melasma should be treated with hormones.
Menopause and melasma: the data point in different directions
A systematic review of 40 studies on menopause and skin disease found mixed outcomes for melasma; some women improved, and some had more melasma outside the face after menopause.
Data on hormone therapy and melasma remain limited
(Roster 2026)
Melasma and the thyroid
A study of 84 women with melasma vs 24 controls found thyroid abnormalities in 58.3% vs 12.5%, mostly autoimmune thyroiditis
(Lutfi 1985)
It is a small, old study, but with melasma, low mood, and insomnia together, a TSH test is worthwhile because thyroid disease can cause all three.
Melasma and mood
Pooling 16 studies with 2,963 people with melasma found depression in 43.4%, with higher odds than in people without melasma (odds ratio 1.677)
(Chen 2024)
Melasma is not only cosmetic. If it makes you avoid people or feel bad about yourself, tell your doctor.
Patches that look like melasma
Dark patches on the cheekbones of Asian women can also be an adult-onset dermal birthmark-like pigmentation, sun spots, or post-inflammatory darkening, each treated differently from melasma.
A dermatologist can tell them apart with examination and dermoscopy before any medicine or laser is used.
so light protection is the foundation, not adding hormones.
5. Melasma care: the right light protection, creams, and tablets with evidence
Direct answer: a sunscreen that blocks both UV and visible light (tinted with iron oxide), plus a wide-brimmed hat, is the base of every treatment.
Creams and tablets speed fading, but melasma returns whenever light protection stops.
Visible light also drives melasma
In a randomized trial of 68 people with melasma all using 4% hydroquinone, those given an iron oxide sunscreen that also blocks visible light
improved 15% more on melasma scores and 28% more on instrument-measured skin color than those using a UV-only sunscreen
(Castanedo-Cazares 2014)
Another trial found that a sunscreen blocking short-wavelength visible light helped prevent melasma from returning after treatment
(Boukari 2015)
Creams: triple combination has the clearest evidence
A Cochrane review of 20 trials with 2,125 participants found that a triple combination of hydroquinone, tretinoin, and fluocinolone acetonide
lightened melasma more than hydroquinone alone (relative risk 1.58), and 20% azelaic acid beat 2% hydroquinone (relative risk 1.25).
The authors noted that most studies were of poor quality and that melasma comes back
(Rajaratnam 2010)
These creams should be used as a dermatologist directs, because long use can thin the skin, irritate it, or cause other dark marks.
Never buy melasma creams that do not list their ingredients, because some are illegally mixed with banned substances or steroids.
Tranexamic acid tablets
In a randomized trial of 44 people with moderate-to-severe melasma, tranexamic acid 250 mg twice daily for 3 months lowered melasma scores by 49% vs 18% with placebo,
and 3 months after stopping the reduction from baseline was 26% vs 19%
(Del Rosario 2018)
Pooling 11 studies with 667 participants found mainly minor side effects, such as lighter periods and stomach discomfort
(Kim 2017)
Because this medicine affects clotting, anyone with a history of blood clots or stroke, or who is using estrogen-containing hormones, needs a doctor’s assessment first.
- Tinted sunscreen that lists iron oxide: apply every morning even indoors, and reapply every 2 hours outdoors
- Wide-brimmed hat and umbrella: cover what sunscreen misses
- No harsh scrubs, home peels, or products that sting: irritation darkens pigmentation
- Photograph your face in the same light every 4 weeks: track progress instead of checking the mirror daily
6. Work stress and thoughts of early retirement: when should you decide?
Direct answer: perimenopause symptoms, broken sleep, and low mood genuinely reduce work capacity, but many of these improve with care.
So avoid big decisions that cannot be undone while symptoms are still untreated; treat first, then reassess.
Evidence on menopause and work
The Menopause Society’s 2024 recommendations conclude that hot flashes, sleep problems, and mood symptoms are linked with lower productivity, absence,
and even early exit from work, and urge employers to adjust hours and conditions as needed
(Menopause Society 2024)
A survey of 619 women with frequent hot flashes found 90.8% said symptoms disturbed sleep, and 83.1% of them felt less productive at work.
The survey was funded by a drug company, so read it as supporting data
(DePree 2023)
CBT for working women
A randomized trial of 124 working women aged 45–60 from 8 organizations found a self-help CBT booklet reduced how problematic hot flashes felt at both 6 and 20 weeks,
improved sleep and work adjustment, and reduced working while unwell at 20 weeks
(Hardy 2018)
Separate “I need a break” from “I want to leave”
When sleep is short and mood is low, the mind tends to see fewer options. Early retirement can be the right choice for some, but it is better decided after sleep and mood have improved for at least 2–3 months.
In the meantime, try reversible options first, such as leave, reduced hours, or a temporary change in duties.
- Write down your top 3 sources of work stress: separate workload, people, and your own symptoms
- Talk to HR or your manager about adjustments: flexible start times, a cooler room, or short breaks
- Check your pension, social security, and savings: before setting a leaving date
- Schedule a decision review 8–12 weeks after starting treatment: if you still want to retire once symptoms improve, the decision is clearer
7. Preparing for a doctor visit: which tests help, and what treatments exist
Direct answer: in women aged 45 and over with clear symptoms, doctors diagnose perimenopause mainly from bleeding pattern and symptoms. Tests that help rule out other causes are TSH,
a blood count, and a pregnancy test. Treatment is chosen by which symptom disrupts daily life more than the others.
FSH: limited information
A single FSH result cannot confirm or rule out perimenopause, because FSH and estrogen swing from cycle to cycle in this phase, which is why STRAW+10 relies on bleeding pattern
(STRAW+10)
FSH is more useful in specific situations, such as being under 45 or having had a hysterectomy so periods cannot be tracked.
TSH: check because the thyroid can mimic every symptom
An overactive thyroid causes palpitations, sweating, insomnia, and irritability; an underactive thyroid causes fatigue, low mood, and irregular periods; and autoimmune thyroiditis appears alongside melasma more often than in the general population
(Lutfi 1985)
Other tests often done alongside
A blood count if periods are heavy, a pregnancy test if a period is late, blood sugar and lipids for age, and breast and cervical screening on schedule.
If bleeding is out of pattern, your doctor may add an ultrasound or an endometrial check.
Hormone therapy: helps hot flashes and sleep, and mood in some groups
Hormone therapy works clearly for hot flashes and night sweats, and for women under 60 or within 10 years of menopause without contraindications the benefits usually outweigh the risks
(NAMS 2022)
In 50 perimenopausal women with depression, 12 weeks of transdermal estradiol led to remission in 68% vs 20% with placebo
(Soares 2001)
and in 172 women without depression, transdermal estradiol plus micronized progesterone for 12 months reduced clinically significant depressive symptoms from 32.3% to 17.3%,
with the benefit seen in the early transition
(Gordon 2018)
The 2018 guideline still makes antidepressants and psychotherapy the main treatments for depression, and hormone therapy is not approved to treat depression
(Maki 2018)
Women with melasma should mention it before starting hormones, because effects on melasma are inconsistent.
Non-hormonal options
The 2023 guideline recommends CBT, clinical hypnosis, SSRI and SNRI medicines such as escitalopram and venlafaxine, gabapentin, and fezolinetant for hot flashes
(NAMS 2023)
SSRIs and SNRIs can therefore help both mood and hot flashes in the same person. Soy is fine as food, but isoflavone pills did not reduce menopausal symptoms in a trial:
248 women taking 200 mg of isoflavones daily for 2 years had more hot flashes than the placebo group
(Levis 2011)
Magnesium and L-theanine
Studies of these supplements for sleep are small and low quality. They can be an add-on if you do not have kidney disease, but should not replace CBT-I or depression treatment,
and you should tell your doctor whenever you combine them with other medicines.
- Record your last 6–12 months of periods: dates, number of days, and flow
- Record 2 weeks of sleep and mood: waking times, sweating, and a 0–10 mood score
- Depression history: when it happened, medicines used, which worked, and side effects
- Photos of your melasma and the products you use: so a dermatologist can check ingredients
- Questions to ask: is hormone therapy right for me, which antidepressant also helps hot flashes, and where can I start CBT-I?
Table: each symptom, what it relates to, and what you can start
Summarized from the research in this article, to prepare for a doctor visit, not for diagnosis
| Symptom | Related factors | Test or ask your doctor | Start now |
|---|---|---|---|
| Waking at 3 a.m. and struggling to fall back asleep | Night-time hot flashes, lighter late-night sleep, depression | Depression screening, TSH, and ask about CBT-I | Cool room, fixed wake time, leave bed if awake more than 20 minutes |
| Low mood, less tolerance for stress | Past depression, hormone swings, short sleep | Standard screening questionnaire, and antidepressant or psychotherapy options | Keep exercising, structured mindfulness, tell someone close |
| Melasma on both cheekbones | Sunlight, visible light, hormones, genetics | Dermatologist to rule out lookalikes, and TSH | Tinted sunscreen, wide-brimmed hat, no scrubbing |
| Periods several months apart | Late perimenopause | Pregnancy test, and report out-of-pattern bleeding | Keep a period diary and continue contraception |
| Palpitations, sweating, weight change | Hot flashes, thyroid, anxiety | TSH, and an ECG if palpitations are frequent | Cut caffeine and note when symptoms occur |
Table: comparing options for sleep, mood, and melasma
Drug classes and generic names only. The right choice depends on symptoms, other conditions, and your doctor’s assessment
| Option | Best for | Evidence | Cautions |
|---|---|---|---|
| CBT-I | Chronic insomnia, night waking | First line per ACP 2016; normal insomnia scores in 70% vs 24% at 8 weeks | More daytime sleepiness at first |
| Hormone therapy (estradiol with micronized progesterone) | Hot flashes and night sweats that wake you | Clearly effective for hot flashes (NAMS 2022); helps mood in the early transition | Not for those with a history of breast cancer, blood clots, or stroke |
| SSRI or SNRI antidepressants (escitalopram, sertraline, venlafaxine) | Returning depression, or low mood with hot flashes | Main treatment per Maki 2018; reduce hot flashes per NAMS 2023 | Take 2–6 weeks to work; do not stop suddenly on your own |
| MBCT (mindfulness with CBT) | People with past depression who are now better | Lowers relapse, hazard ratio 0.69 in 1,258 people | Not a replacement for treatment during a severe episode |
| Moderate aerobic exercise | Everyone, as the base of the plan | Reduces depressive symptoms, standardized mean difference 1.11 across 25 trials | Hard exercise close to bedtime can delay sleep for some |
| Tinted sunscreen (iron oxide) | Everyone with melasma | 15% more improvement than UV-only sunscreen, and fewer relapses | Must be reapplied outdoors |
| Triple combination cream or azelaic acid | Visible melasma after light protection is in place | Triple combination beats hydroquinone alone (Cochrane) | Use as a dermatologist directs; can irritate |
| Oral tranexamic acid | Moderate-to-severe melasma | Melasma scores down 49% vs 18% at 3 months | Not for those with a history of blood clots or stroke |
| Isoflavone pills, magnesium, or L-theanine | People who want to try an add-on | Isoflavones did not reduce menopausal symptoms in a 2-year trial; sleep supplements have limited evidence | Not a substitute for depression treatment; take care with magnesium in kidney disease |
Common beliefs vs the evidence
Melasma appears because estrogen falls at menopause
Not supported. Melasma is linked with times of greater sex-hormone exposure, such as pregnancy and hormonal contraception, together with light. The average age at onset is 34.
You wake at 3 a.m. because of a cortisol spike
Cortisol rises in the early morning in everyone, but there is no evidence it is the main cause. Hot flashes and depression are more clearly linked with night waking.
Estrogen falls, serotonin falls, and that causes depression
Too simple. Mood in this phase reflects hormone swings, past depression, sleep, and stress together. A single-chemical explanation can lead people to overlook treatments that work.
An FSH test tells you whether you are in menopause
For women aged 45 and over with clear symptoms, bleeding pattern tells more. A single FSH result swings with the cycle and can mislead.
Phytoestrogens can replace hormone therapy
Soy is fine as food, but high-dose isoflavone pills did not reduce menopausal symptoms in a 2-year trial, and they do not replace depression treatment.
Severe menopause symptoms mean you should retire now
Retiring can be the right decision, but it is better made after sleep and mood have improved with treatment, and after trying reversible options first.
Magnesium or L-theanine fixes 3 a.m. waking
The evidence is small and low quality. They may help some people as an add-on, but CBT-I and treating hot flashes or depression have clearer evidence.
Frequently Asked Questions (FAQ)
Why does perimenopause make you wake at 3 a.m. and struggle to fall back asleep?
Sleep is lighter in the second half of the night, so a mild hot flash, a full bladder, or racing thoughts wake you easily. Following 3,045 women showed that more frequent hot flashes meant more night waking. Cortisol rising in the early morning is normal for everyone, but there is no evidence it is the main cause. Women with past depression should also be screened, because waking early is a symptom of depression.
I had depression before. Will it come back during menopause?
The chance is higher. The SWAN study found the odds of major depression were 2–4 times higher during perimenopause or early postmenopause than before the transition, and a history of depression was a strong predictor. If low mood, loss of interest, or feeling worthless lasts nearly every day for more than 2 weeks, see a doctor, and if you have thoughts of self-harm, call emergency services or 1323 or 1669 in Thailand.
Is melasma on both cheekbones related to menopause?
Partly, but melasma is not caused by falling estrogen. It is linked with high or fluctuating sex hormones, sunlight, visible light, and genetics. A survey of 324 women found an average onset age of 34, and 48% had a family history. A dermatologist should rule out other dark patches before treatment.
Which blood tests should I have, and can FSH tell me I am in menopause?
For women aged 45 and over with clear symptoms, doctors rely mainly on bleeding pattern and symptoms. A single FSH result cannot confirm or rule out perimenopause because it swings with each cycle. Tests that help rule out other causes are TSH, a blood count, and a pregnancy test, plus blood sugar and lipids for age.
Can hormone therapy help sleep, mood, and melasma?
Hormone therapy works clearly for hot flashes and night sweats that wake you, and trials show transdermal estradiol can help depression during the transition. However, hormone therapy is not approved to treat depression; antidepressants and psychotherapy remain the main treatments. Effects on melasma are inconsistent, so mention melasma to your doctor before starting.
Which sunscreen helps melasma, and what treatments exist?
Choose a tinted sunscreen with iron oxide, because it also blocks visible light; a trial found more improvement than with UV-only sunscreen. Treatments with evidence include a triple combination cream of hydroquinone, tretinoin, and fluocinolone acetonide, azelaic acid, and oral tranexamic acid, which lowered melasma scores by 49% vs 18% at 3 months. All should be used as a dermatologist directs.
I already meditate and exercise. Why is my mood still low, and what else can I do?
Exercise and mindfulness genuinely help, but perimenopause adds extra risk. Still feeling low means treatment needs adding, not that you are not doing enough. Options include MBCT, which lowers depressive relapse (hazard ratio 0.69), antidepressants that can also ease hot flashes, CBT-I for sleep, and discussing hormone therapy with your doctor.
Work stress makes me want to retire early. Should I decide now?
Perimenopause symptoms do reduce work performance and are linked with leaving work early, but many improve with care. Avoid big decisions that cannot be undone while symptoms are still untreated. Try leave, reduced hours, or adjusted duties first, then review again 8–12 weeks after starting treatment.
Scientific mechanism
Swinging hormones and the temperature center: in late transition, ovulation becomes irregular, estrogen swings widely, and progesterone falls because it is made only after ovulation.
The hypothalamic temperature center becomes more sensitive, so slight warmth during sleep triggers skin vessel widening, sweating, and waking
(Kravitz 2008,
Freedman 2006)
Hormone sensitivity and the stress-response system: current models propose that estrogen swings affect brain neurosteroids that tune GABA receptors,
as well as the hypothalamic-pituitary-adrenal axis. Women sensitive to these changes, including those with past depression, therefore react more strongly to stress
(Gordon 2015)
Melasma involves several systems together: UV and visible light stimulate pigment cells in the skin, while progesterone receptors in the epidermis and estrogen receptors around dermal blood vessels in melasma patches
make those areas respond more to hormones than the surrounding skin
(Jang 2010,
Castanedo-Cazares 2014)
Tranexamic acid dampens vascular and inflammatory signals that stimulate pigment, which explains why a clotting medicine works for melasma.
Compiled and reviewed by Asst. Prof. Dr. Norawit Raatpiboon
Academic references (E-E-A-T)
- Harlow SD et al. Executive summary of the Stages of Reproductive Aging Workshop + 10. Menopause 2012 (PMID 22343510)
- Kravitz HM et al. Sleep disturbance during the menopausal transition in a multi-ethnic community sample of women. Sleep 2008 (PMID 18652093)
- Freedman RR, Roehrs TA. Effects of REM sleep and ambient temperature on hot flash-induced sleep disturbance. Menopause 2006 (PMID 16837879)
- Woods NF et al. Cortisol levels during the menopausal transition and early postmenopause. Menopause 2009 (PMID 19322116)
- Qaseem A et al. Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians. Ann Intern Med 2016 (PMID 27136449)
- McCurry SM et al. Telephone-Based Cognitive Behavioral Therapy for Insomnia in Perimenopausal and Postmenopausal Women With Vasomotor Symptoms: A MsFLASH Randomized Clinical Trial. JAMA Intern Med 2016 (PMID 27213646)
- Bromberger JT et al. Major depression during and after the menopausal transition: Study of Women’s Health Across the Nation (SWAN). Psychol Med 2011 (PMID 21306662)
- Colvin A et al. The role of family history of depression and the menopausal transition in the development of major depression in midlife women (SWAN MHS). Depress Anxiety 2017 (PMID 28489293)
- Freeman EW et al. Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch Gen Psychiatry 2006 (PMID 16585466)
- Badawy Y et al. The risk of depression in the menopausal stages: a systematic review and meta-analysis. J Affect Disord 2024 (PMID 38642901)
- Maki PM et al. Guidelines for the evaluation and treatment of perimenopausal depression: summary and recommendations. Menopause 2018 (PMID 30179986)
- Gordon JL et al. Ovarian hormone fluctuation, neurosteroids, and HPA axis dysregulation in perimenopausal depression: a novel heuristic model. Am J Psychiatry 2015 (PMID 25585035)
- Soares CN et al. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry 2001 (PMID 11386980)
- Gordon JL et al. Efficacy of transdermal estradiol and micronized progesterone in the prevention of depressive symptoms in the menopause transition: a randomized clinical trial. JAMA Psychiatry 2018 (PMID 29322164)
- Kuyken W et al. Efficacy of Mindfulness-Based Cognitive Therapy in Prevention of Depressive Relapse: An Individual Patient Data Meta-analysis From Randomized Trials. JAMA Psychiatry 2016 (PMID 27119968)
- Schuch FB et al. Exercise as a treatment for depression: A meta-analysis adjusting for publication bias. J Psychiatr Res 2016 (PMID 26978184)
- Ortonne JP et al. A global survey of the role of ultraviolet radiation and hormonal influences in the development of melasma. J Eur Acad Dermatol Venereol 2009 (PMID 19486232)
- Jang YH et al. Oestrogen and progesterone receptor expression in melasma: an immunohistochemical analysis. J Eur Acad Dermatol Venereol 2010 (PMID 20337826)
- Roster K et al. Menopause and Common Dermatoses: A Systematic Review. Am J Clin Dermatol 2026 (PMID 41331233)
- Lutfi RJ et al. Association of melasma with thyroid autoimmunity and other thyroidal abnormalities and their relationship to the origin of the melasma. J Clin Endocrinol Metab 1985 (PMID 3923030)
- Chen W et al. Prevalence of depression in melasma: a systematic review and meta-analysis. Front Psychiatry 2024 (PMID 38260775)
- Castanedo-Cazares JP et al. Near-visible light and UV photoprotection in the treatment of melasma: a double-blind randomized trial. Photodermatol Photoimmunol Photomed 2014 (PMID 24313385)
- Boukari F et al. Prevention of melasma relapses with sunscreen combining protection against UV and short wavelengths of visible light: a prospective randomized comparative trial. J Am Acad Dermatol 2015 (PMID 25443629)
- Rajaratnam R et al. Interventions for melasma. Cochrane Database Syst Rev 2010 (PMID 20614435)
- Del Rosario E et al. Randomized, placebo-controlled, double-blind study of oral tranexamic acid in the treatment of moderate-to-severe melasma. J Am Acad Dermatol 2018 (PMID 28987494)
- Kim HJ et al. Efficacy and Safety of Tranexamic Acid in Melasma: A Meta-analysis and Systematic Review. Acta Derm Venereol 2017 (PMID 28374042)
- The Menopause Society. Menopause and the workplace: consensus recommendations from The Menopause Society. Menopause 2024 (PMID 39186451)
- Hardy C et al. Self-help cognitive behavior therapy for working women with problematic hot flushes and night sweats (MENOS@Work): a multicenter randomized controlled trial. Menopause 2018 (PMID 29315132)
- DePree B et al. Association of menopausal vasomotor symptom severity with sleep and work impairments: a US survey. Menopause 2023 (PMID 37625086)
- The North American Menopause Society. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause 2022 (PMID 35797481)
- The North American Menopause Society. The 2023 nonhormone therapy position statement of The North American Menopause Society. Menopause 2023 (PMID 37252752)
- Levis S et al. Soy isoflavones in the prevention of menopausal bone loss and menopausal symptoms: a randomized, double-blind trial. Arch Intern Med 2011 (PMID 21824950)
Medical Disclaimer
This article provides general information about perimenopause, sleep, depression, and melasma. It is not a diagnosis, prescription, or personal treatment plan.
Medicine names are drug classes or generic names for education only. Do not start, stop, or change antidepressants, hormones, or melasma medicines on your own.
If you have thoughts of self-harm, call emergency services (in Thailand, 1323 or 1669) or go to the nearest hospital now.